Published in Presse Med on October 19, 2002
Impact of clinical and patient-reported outcomes on patient satisfaction with cataract extraction. Health Expect (2012) 0.99
Measuring the impact of cataract surgery on generic and vision-specific quality of life. Qual Life Res (2012) 0.88
Cost-effectiveness sequential modeling of ranibizumab versus usual care in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2008) 0.86
Botulinum toxin in hemifacial spasm: the challenge to assess the effect of treatment. J Neural Transm (Vienna) (2012) 0.83
Visual outcome and impact on quality of life after surgeries differ in children operated for unilateral and bilateral cataract (Pune study 2011). Oman J Ophthalmol (2012) 0.78
Perspectives on Quality of Life in Glaucoma. J Curr Glaucoma Pract (2012) 0.75
Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases. Br J Ophthalmol (2003) 3.66
High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma. Arch Dermatol (1995) 2.00
Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma. Blood (2000) 1.59
Corneal endothelial cell apoptosis in patients with Fuchs' dystrophy. Invest Ophthalmol Vis Sci (2000) 1.57
Screening human donor corneas during organ culture for the presence of guttae. Br J Ophthalmol (2001) 1.56
Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UK. Hum Reprod (2001) 1.52
Cloning and characterization of the murine toll-like receptor 5 (Tlr5) gene: sequence and mRNA expression studies in Salmonella-susceptible MOLF/Ei mice. Genomics (2000) 1.49
Recombinant congenic strains derived from A/J and C57BL/6J: a tool for genetic dissection of complex traits. Genomics (2001) 1.42
Salmonella enterica serovar typhimurium waaP mutants show increased susceptibility to polymyxin and loss of virulence In vivo. Infect Immun (2000) 1.32
Donor organ cultured corneal tissue selection before penetrating keratoplasty. Br J Ophthalmol (1998) 1.23
Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes. J Invest Dermatol (1989) 1.21
A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy. J Clin Endocrinol Metab (2003) 1.20
Adalimumab: a new modality for Behçet's disease? Ann Rheum Dis (2006) 1.20
Cellular immune response in Echinococcus multilocularis infection in humans. II. Natural killer cell activity and cell subpopulations in the blood and in the periparasitic granuloma of patients with alveolar echinococcosis. Clin Exp Immunol (1989) 1.17
Endophthalmitis after Lasiodiplodia theobromae corneal abscess. Graefes Arch Clin Exp Ophthalmol (1997) 1.11
Validation of the Multiple Sclerosis International Quality of Life questionnaire. Mult Scler (2007) 1.10
Morphology, histology, and ultrastructure of human C31 organ-cultured corneas. Cornea (1995) 1.09
Inhibition of autoimmune disease in a murine model of systemic lupus erythematosus induced by exposure to syngeneic photoinactivated lymphocytes. J Invest Dermatol (1990) 1.04
Resistance of Acanthamoeba to classic DNA extraction methods used for the diagnosis of corneal infections. Br J Ophthalmol (2007) 1.03
Secondary Fuchs's heterochromic cyclitis: a new approach to an old disease. Ophthalmologica (1985) 1.02
Evaluation of the deswelling period in dextran-containing medium after corneal organ culture. Cornea (1997) 1.02
Microbiologic study of organ-cultured donor corneas. Transplantation (1998) 1.01
Identification of genetic loci controlling bacterial clearance in experimental Salmonella enteritidis infection: an unexpected role of Nramp1 (Slc11a1) in the persistence of infection in mice. Genes Immun (2002) 1.00
[Urrets-Zavalia syndrome]. J Fr Ophtalmol (2001) 0.99
Thymocyte subpopulations in young and adult mice. I. Separation by density gradient and steroid treatment. Eur J Immunol (1977) 0.98
AIDS in a Haitian woman with cardiac Kaposi's sarcoma and Whipple's disease. Lancet (1983) 0.98
Interleukin-7 is a growth factor for Sézary lymphoma cells. J Clin Invest (1992) 0.96
Results of the MITRA project: monitoring and intervention for the transportation of dangerous goods. J Hazard Mater (2007) 0.95
New test for the diagnosis of bacterial endophthalmitis. Br J Ophthalmol (2009) 0.94
[Möbius syndrome: ocular and clinical manifestations]. J Fr Ophtalmol (2007) 0.94
The results of successful penetrating keratoplasty using donor organ-cultured corneal tissue. Transplantation (1999) 0.93
Synoviocyte infection with adeno-associated virus (AAV) is neutralized by human synovial fluid from arthritis patients and depends on AAV serotype. Hum Gene Ther (2007) 0.93
Cost-effectiveness modeling of intrathecal baclofen therapy versus other interventions for disabling spasticity. Neurorehabil Neural Repair (2009) 0.93
[Muscular damage during isotretinoin treatment]. Ann Dermatol Venereol (1998) 0.92
Inhibition of anti-skin allograft immunity induced by infusions with photoinactivated effector T lymphocytes--the congenic model. Transplantation (1991) 0.92
ABO antigen blood-group compatibility in corneal transplantation. Cornea (1997) 0.92
T cell imbalance in nonleukemic and leukemic cutaneous lymphoma defined by monoclonal antibodies. Clin Immunol Immunopathol (1981) 0.91
Cost-effectiveness modeling of dental implant vs. bridge. Clin Oral Implants Res (2009) 0.90
Automated keratoconus detection using the EyeSys videokeratoscope. J Cataract Refract Surg (2000) 0.90
[Chronic blepharoconjunctivitis during a treatment with acitretin (Soriatane)]. J Fr Ophtalmol (1993) 0.89
[Micro-endoscopy of the lacrimal apparatus combined with Erbium YAG laser: an anatomical study. New methods of imaging]. J Fr Ophtalmol (1999) 0.89
[Posterior acute ischemic optic neuropathy (author's transl)]. J Fr Ophtalmol (1982) 0.89
[Fungal keratitis caused by Cylindrocarpon lichenicola]. J Fr Ophtalmol (2011) 0.88
[Treatment of unilateral limbal stem cell deficiency syndrome by limbal autograft]. J Fr Ophtalmol (1999) 0.88
Assessing the cost-effectiveness of biologic agents for the management of moderate-to-severe rheumatoid arthritis in anti-TNF inadequate responders in Italy: a modelling approach. Clin Exp Rheumatol (2011) 0.88
[Anterior and posterior acute ischemic optic neuropathy related to poly-arteritis nodosa (author's transl)]. J Fr Ophtalmol (1982) 0.88
Expression of V beta gene segments by Sezary cells. J Invest Dermatol (1995) 0.88
Treatment of parvovirus B19-associated polyarteritis nodosa with intravenous immune globulin. N Engl J Med (2001) 0.87
[Cornea guttata and Fuchs' dystrophy]. J Fr Ophtalmol (1999) 0.87
Outcome of Corneal transplantation rejection. Cornea (2001) 0.87
Cryopreservation and culture of human corneal keratocytes. Invest Ophthalmol Vis Sci (1998) 0.87
[Prevention of proliferative vitreoretinopathy using 5-FU heparin: clinical tolerance and efficacy]. J Fr Ophtalmol (2005) 0.86
[Orbscan: a new device for iridocorneal angle measurement]. J Fr Ophtalmol (2002) 0.86
Influencing factors on the suitability of organ-cultured corneas. Eye (Lond) (2010) 0.86
Cost-effectiveness sequential modeling of ranibizumab versus usual care in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2008) 0.86
The Spectrum of Cutaneous Lymphomas in HIV infection: a study of 21 cases. Am J Surg Pathol (1999) 0.86
[Acute bilateral retinal necrosis in 2 stages. The role of herpes infection?]. Bull Soc Ophtalmol Fr (1985) 0.86
[Contrast sensitivity and diabetes]. Bull Soc Ophtalmol Fr (1990) 0.86
Effects of topical anaesthetics and fluorescein on the real-time PCR used for the diagnosis of Herpesviruses and Acanthamoeba keratitis. Br J Ophthalmol (2006) 0.85
[Ocular response analyzer: feasibility study and correlation with normal eyes]. J Fr Ophtalmol (2007) 0.85
Guidelines on the use of extracorporeal photopheresis. J Eur Acad Dermatol Venereol (2014) 0.85
Localization and characterization of substance P binding sites in rat and rabbit eyes. Invest Ophthalmol Vis Sci (1991) 0.85
Prognostic factors in primary cutaneous lymphomas other than mycosis fungoides and the Sézary syndrome. The French Study Group on Cutaneous Lymphomas. Blood (1999) 0.84
Effect of sumatriptan, a 5HT1 agonist, on the frequency of transient lower esophageal sphincter relaxations and gastroesophageal reflux in healthy subjects. Am J Gastroenterol (1999) 0.84
Cutaneous involvement in patients with angioimmunoblastic lymphadenopathy with dysproteinemia: a clinical, immunohistological, and molecular analysis. Arch Dermatol (2000) 0.84
HTLV-1 provirus and mycosis fungoides. Science (1993) 0.84
Effects of penetrating keratoplasty suture removal on corneal topography and refraction. Cornea (1999) 0.84
[A study of pupil dilation using the Mydriasert ophthalmic insert]. J Fr Ophtalmol (2004) 0.83
[Activity and epidemiology in an ophthalmological emergency center]. J Fr Ophtalmol (2002) 0.83
Use of ocular hypotensive prostaglandin analogues in patients with uveitis: does their use increase anterior uveitis and cystoid macular oedema? Br J Ophthalmol (2008) 0.83
Familial pseudotumoral sclerochoroidal calcification associated with chondrocalcinosis. Br J Ophthalmol (2004) 0.83
CGI-58/ABHD5 gene is mutated in Dorfman-Chanarin syndrome. Am J Med Genet A (2004) 0.83
Suspected bacterial endophthalmitis following intravitreal anti-VEGF injection: case series and literature review. Ophthalmologica (2012) 0.83
Cost-effectiveness modelling of sequential biologic strategies for the treatment of moderate to severe rheumatoid arthritis in Finland. Open Rheumatol J (2012) 0.83
[Pharmacological adjuvants for surgical treatment of proliferative vitreoretinopathy]. J Fr Ophtalmol (2004) 0.83
[Susac syndrome and ocular manifestation in a 14-year-old girl]. J Fr Ophtalmol (2007) 0.83
Acquired and transient factor X deficiency associated with sodium valproate treatment. Eur J Haematol (1996) 0.83
[Systemic mastocytosis and malignant mastocytosis]. Presse Med (1990) 0.83
Tissue crossmatch before corneal transplantation. Br J Ophthalmol (2004) 0.82
Surgical correction of postkeratoplasty astigmatism with the Hanna arcitome. J Cataract Refract Surg (1999) 0.82
Human epithelial cell cultures from superficial limbal explants. Mol Vis (2011) 0.82
Nonneoplastic circulating Sézary-like cells in cutaneous T-cell lymphoma. Ultrastructural, immunologic, and T-cell receptor gene-rearrangement studies. Cancer (1987) 0.82
Rapid detection and quantification of Propionibacteriaceae. Br J Ophthalmol (2008) 0.82
Influence of fetal calf serum, fibroblast growth factors, and hepatocyte growth factor on three-dimensional cultures of human keratocytes in collagen gel matrix. Graefes Arch Clin Exp Ophthalmol (1999) 0.82
[Bird-shot chorioretinopathy after retinal detachment: probable autoimmune origin]. Bull Soc Ophtalmol Fr (1983) 0.82
[Severe Moorens ulcer: efficacy of monthly cyclophosphamide intravenous pulse treatment]. Rev Med Interne (2003) 0.82
Measurement of irregular astigmatism using semimeridian data from videokeratographs. J Refract Surg (1997) 0.81
[Clinical management and prognosis in Acanthamoeba keratitis: a retrospective study of 25 cases]. J Fr Ophtalmol (2002) 0.81
[Ocular manifestations of arachnoid cysts in children: report of two cases]. J Fr Ophtalmol (2013) 0.81
Uveitis in a patient receiving rifabutin for Crohn's disease. J R Soc Med (2004) 0.81
No evidence for HTLV-I infection in 24 cases of French and Portuguese mycosis fungoïdes and Sezary syndrome (as seen in France). Leukemia (1991) 0.81
Regulation of human corneal epithelial cell proliferation and apoptosis by dexamethasone. Invest Ophthalmol Vis Sci (2000) 0.81
Digital angiography for the diagnosis of dural sinus thrombosis in Behçet's disease. Arthritis Rheum (1985) 0.81
Lichen planus pemphigoides: an immuno-electron microscopic study. Br J Dermatol (1985) 0.81
[Heavy silicone oil as internal tamponade for retinal detachment: efficacy and tolerance]. J Fr Ophtalmol (2006) 0.81
In vitro effects of dexamethasone on human corneal keratocytes. Invest Ophthalmol Vis Sci (1999) 0.81
[Exudative retinopathy with dominant transmission. Report of a new pedigree]. J Fr Ophtalmol (1985) 0.81
New anionic polyelectrolyte hydrogel for corneal surgery. J Biomed Mater Res (1997) 0.81
[Lymphangioma of the orbit]. J Fr Ophtalmol (1985) 0.80
Ocular findings following intravitreal silicone injection. Arch Ophthalmol (1983) 0.80